Clinical Trials Directory

Trials / Unknown

UnknownNCT05723003

Prospective Validation of an Acute Pulmonary Embolism Severity and Prognosis Prediction Model

Multicenter Prospective Validation and Extension of the 'PUMCH' Acute Pulmonary Embolism Severity and Prognosis Prediction Model

Status
Unknown
Phase
Study type
Observational
Enrollment
4,000 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to prospectively validate the first PUMCH model for acute PE severity and prognosis prediction based on multi-center data constructed in the pre-project period based on national population data, and to optimize the PUMCH model based on artificial intelligence clustering algorithm.

Detailed description

Patients with pulmonary embolism and aged 18 years or older were enrolled in this study.Patient demographic characteristics(age, sex, department, diagnosis), basic vital signs, symptoms at their admissions (hemoptysis, dyspnea, chest pain, syncope, laboratory examinations (blood lab routines, blood gas, liver and kidney function, myocardial marker), and imaging examinations (vascular ultrasonography, computed tomographic angiography, echocardiography, chest CT,CTPA, pulmonary perfusion imaging, pulmonary angiography, PET/CT) were prospectively collected. Patients were followed up every 1/3/6 months to obtain survival outcomes.

Conditions

Timeline

Start date
2023-02-01
Primary completion
2025-01-01
Completion
2025-10-30
First posted
2023-02-10
Last updated
2023-02-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05723003. Inclusion in this directory is not an endorsement.

Prospective Validation of an Acute Pulmonary Embolism Severity and Prognosis Prediction Model (NCT05723003) · Clinical Trials Directory